Match each patient's clinical presentation with the most accurate diagnosis and guideline-concordant management step.
- A 32-year-old woman with profuse, purulent vaginal discharge, intense vaginal erythema, and dyspareunia. Vaginal pH is 5.5. Microscopy reveals numerous parabasal cells and >10 leukocytes per high-power field, but no clue cells, yeast, or motile organisms.Desquamative inflammatory vaginitis; treat with intravaginal clindamycin or topical hydrocortisone.
- A 28-year-old woman with thick, white vaginal discharge and severe pruritus. Wet mount shows budding yeast. She has had four similar, culture-confirmed episodes in the past 12 months.Recurrent vulvovaginal candidiasis; treat with 10-14 days of induction oral fluconazole followed by 6 months of weekly maintenance therapy.
- A 24-year-old woman with bilateral lower abdominal pain, cervical motion tenderness, and fever. She has a levonorgestrel intrauterine device (IUD) placed 3 years ago. Pelvic ultrasound shows no adnexal masses.Pelvic inflammatory disease; treat with intramuscular ceftriaxone, oral doxycycline, and oral metronidazole; leave the intrauterine device in place.
- A 21-year-old woman with malodorous, frothy discharge and punctate cervical hemorrhages. Microscopy shows flagellated, motile organisms. She completed a 7-day course of metronidazole two weeks ago; her sole partner was also treated concurrently.Refractory trichomoniasis; treat with high-dose oral metronidazole or tinidazole for 7 days.
Cevap
Match the patient with parabasal cells to Desquamative inflammatory vaginitis; the patient with 4+ yeast episodes to Recurrent candidiasis; the IUD patient to Pelvic inflammatory disease (leaving IUD in place); and the patient who failed initial therapy to Refractory trichomoniasis.
Each pair correctly links a complex or atypical presentation of a gynecologic infection with its most appropriate, evidence-based management strategy.
Adım Adım Çözüm
Anahtar Kavram
The management of complex gynecologic infections requires synthesizing wet mount findings (e.g., parabasal cells in DIV), recognizing chronicity (RVVC and refractory trichomoniasis), and applying specific guidelines for foreign bodies like an IUD during active infection.